Honored Visit from Revvity’s Global Leadership
It was a true privilege to welcome Dr. Prahlad Singh, President and Chief Executive Officer of Revvity (formerly PerkinElmer), and Mr. Kyon SoonPil, Vice President and General Manager, Commercial GGM, to our lab.
Their visit marks an important milestone in our shared vision of advancing precision medicine and translational research. Revvity’s technologies have long powered our work—from high-content imaging to multi-omics analytics—driving innovation in systems pharmacology, spatial biology, and cancer precision medicine.
Looking ahead, our collaboration will expand to include joint laboratory initiatives, training and summer school programs, and co-development of platforms that bridge academia, industry, and clinical applications across the Asia-Pacific region.
We are deeply honored by their recognition and look forward to building a future of science-driven impact together.
